Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPE-CF: Continuous vs Intermittent Piperacillin-Tazobactam in Cystic Fibrosis
NCT01694069Phase 4Terminated
- Sponsor
- West Virginia University
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam in Pseudomonas aeruginosa infection, sponsored by West Virginia University. Started Sep 2012; status: terminated.
02
Drugs
piperacillin + tazobactam
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01694069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694069.